OVERVIEW

Global Health Architecture is key to Indonesia’s G20 Presidency with emphasis on building global health resilience through strengthening the financing system for global commons for pandemic prevention, preparedness and response, including equitable access to treatment and vaccination for lower income countries.

Leveraging on resources from the public, private, philanthropic sectors, and the international financial institutions, the Global Health Architecture would help strengthen preparedness at country level and regional institutions through investment in health surveillance and detection, public health laboratories, institutional capacity strengthening, human resources, health system strengthening and others. It will also focus on R&D for future and emerging infectious diseases, boosting production capacity, ensuring equitable access to medical counter-measures, supply chains and stockpiling, where Indonesia may act as the global hub.

$30 Billion “Health of Nations” BioFund

This $30 Billion “Health of Nations” Fund explores a new global funding model for the R&D and biomedical innovation creating cures for debilitating diseases, ensuring new life-saving drugs can be brought to the patients, which otherwise may not have been developed because of financial risks.

Developed by Prof Andrew Lo, Professor of Finance at the MIT Sloan School of Management, the new financial approach looks at investing in a portfolio of medical programs that are uncorrelated and in different stages of lifecycle, from early-stage to late-stage innovations. The new model upends the traditional Venture Capital financing where the risks-rewards time frame does not align with biomedical Innovation. The model can take a blended fund approach utilizing ‘patient’ capital, such as SWF, impact or catalytic capital to mobilise additional private financing.

More information on Prof Andrew Lo’s New Funding Model for Biomedical Innovation

The $30 Billion “Health of Nations” Advisory Council comprises the following distinguished members:

Honorary Chair

H.E. Budi Sadikin, Minister of Health, Republic of Indonesia

Co-Chairs

Sir Gordon Duff, Pro Vice Chancellor Emeritus, Oxford University
Prof. Andrew W. Lo, Charles E. and Susan T. Harris Professor of Finance, MIT Sloan School of Management

Members

Robert C. Merton, School of Management Distinguished Professor of Finance at MIT Sloan School of Management
Tarun Khanna, Jorge Paulo Lemann Professor, Harvard Business School / Lancet India, Chair
Joseph Gatto, Chair of Planetary Health Alliance
Philip Yeo, Chairman of EDIS and Advanced MedTech Singapore
Anousheh Ansari, CEO, The XPrize Foundation
Alfred Scheidegger, Partner, Founder of Nextech Invest
Prof. Wong Tien Yin, Founding Head of Tsinghua Medicine
Raja Kamal, Senior Director of the Medicine International Council of National University of Singapore
Alexandra Eldemir, Managing Director, Global Head of Investment Strategy for BlackRock’s Factors, Sustainable and Solutions Group

To support this initiative, please reach out to